Ellen Cleland, MD
Family Medicine · Chattanooga, TNNPI 1124525423
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $35,357 of the $37,644 with a category attached, or 93.9%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 94.1% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $23,963, more than ten times the $98 reported in 2023. Among family medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $422.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$35K
- Novo Nordisk$547
- Xeris Pharmaceuticals, Inc.$290
- Axsome Therapeutics, Inc.$168
- Bard Peripheral Vascular, Inc.$146
- Otsuka America Pharmaceutical, Inc.$140
- plus $947 from 18 others
What the payments were for
- Consulting fees$35,35794%
- Food & beverage$2,2876%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $35,406 |
| Novo Nordisk | 16 | $547 |
| Xeris Pharmaceuticals, Inc. | 5 | $290 |
| Axsome Therapeutics, Inc. | 3 | $168 |
| Bard Peripheral Vascular, Inc. | 1 | $146 |
| Otsuka America Pharmaceutical, Inc. | 2 | $140 |
| Silk Road Medical, Inc. | 1 | $137 |
| Amgen | 7 | $134 |
| Lilly USA, LLC | 1 | $112 |
| AbbVie | 6 | $112 |
| AstraZeneca | 6 | $90 |
| Exact Sciences | 4 | $75 |
| Bayer | 3 | $62 |
| Astellas Pharma US Inc | 2 | $37 |
| Intra-sana Laboratories | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Resmed Corp | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| GSK | 1 | $16 |
| Pfizer | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| Linus Health, Inc. | 1 | $12 |
| Abbott | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,644 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 22 | $26,544 |
| OzempicSemaglutide | 19 | $21,104 |
| EliquisApixaban | 17 | $19,160 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,068 |
| Potassium Chloride | 23 | $922 |
| Losartan Potassium | 59 | $918 |
| Gabapentin | 52 | $822 |
| Omeprazole | 50 | $764 |
| Atorvastatin Calcium | 59 | $748 |
| Duloxetine Hcl | 23 | $638 |
| Pravastatin Sodium | 27 | $609 |
| Rosuvastatin Calcium | 38 | $574 |
| Levothyroxine Sodium | 56 | $545 |
| Valsartan | 12 | $544 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $536 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $112 | $26,54422 claims |
| Novo NordiskOzempic | $547 | $21,10419 claims |
| PfizerEliquis | $15 | $19,16017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Chattanooga
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Meredith SchweitzerAntioch$37K
- Jason GoolsbyBrownsville$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.